CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes
Key facts
- Who runs it
- Medical University of South Carolina
- Where
- Charleston, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 2
- People taking part
- 46 people enrolled
- Started
- 5 Dec 2023
- Ended
- 5 Nov 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Regular Nicotine patch and lozenge dose
- Augmented Nicotine patch and lozenge dose
- Record updated
- 26 November 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Age 18yrs +
- Daily nicotine-containing e-cigarette user (25+ days per previous month)
- E-cigarette use 5+ times/day
- E-cigarette use > 1year
- Smoking >1 cigarette on 5-7 days per week
- Interest in quitting smoking and e-cigarette within the next month (>7 on 10-point scale)
- Willingness to use NRT
- Able to receive text messages/email
- Mailing address in South Carolina
Who cannot take part
- Individuals reporting current use of other nicotine-containing products and/or smoking cessation medications
- Medical conditions contraindicated to NRT use (including pregnancy, past month myocardial infarction, current cardiac arrhythmia, current angina, uncontrolled vascular disease, or medical conditions in which consumption of phenylalanine is contraindicated)
- Those who vape non-nicotine substances
- Individuals unable to consent (e.g. significant cognitive deficit, non-English speaking)
Where in United States
- Medical University of South Carolina CharlestonCharleston, United States
About the trial
What the trial wants to find out
Many people smoke cigarettes and use e-cigarettes, and have a hard time stopping. Nicotine replacement therapy medications, such as nicotine patches and lozenges, have been shown to help people quit e-cigarette use. The purpose of the present study is to see how well nicotine patches and lozenges help people quit both smoking and vaping, and to determine if higher doses of the medication work best.
The 3 groups in the trial
- Arm AExisting treatment, for comparison
21mg patch, qd + 4mg lozenge prn \[minimum of 5 \& up to 20 per day\]
Treatment: Regular Nicotine patch and lozenge dose
- Arm BExisting treatment, for comparison
21mg patch + 14mg patch qd + 4mg lozenge prn minimum of 5 \& \[up to 30 per day\]
Treatment: Augmented Nicotine patch and lozenge dose
- Arm CExisting treatment, for comparison
2 x 21mg patches qd + 4mg lozenges prn \[minimum of 5 \& up to 40 per day\]
Treatment: Augmented Nicotine patch and lozenge dose
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparing the Effects of Augmented Doses of Nicotine Replacement Therapy on Quitting Cigarettes and E-cigarettes
- Publications
- Augmented Doses of Nicotine Replacement Therapy: Feasibility for Dual Cigarette and E-Cigarette Cessation.American journal of preventive medicine, 2025
- Record updated
- 26 November 2025